Literature DB >> 28267003

Prediction of Pathological Complete Response Using Endoscopic Findings and Outcomes of Patients Who Underwent Watchful Waiting After Chemoradiotherapy for Rectal Cancer.

Kazushige Kawai1, Soichiro Ishihara, Hiroaki Nozawa, Keisuke Hata, Tomomichi Kiyomatsu, Teppei Morikawa, Masashi Fukayama, Toshiaki Watanabe.   

Abstract

BACKGROUND: Nonoperative management for patients with rectal cancer who have achieved a clinical complete response after chemoradiotherapy is becoming increasingly important in recent years. However, the definition of and modality used for patients with clinical complete response differ greatly between institutions, and the role of endoscopic assessment as a nonoperative approach has not been fully investigated.
OBJECTIVE: This study aimed to investigate the ability of endoscopic assessments to predict pathological regression of rectal cancer after chemoradiotherapy and the applicability of these assessments for the watchful waiting approach.
DESIGN: This was a retrospective comparative study. SETTINGS: This study was conducted at a single referral hospital. PATIENTS: A total of 198 patients with rectal cancer underwent preoperative endoscopic assessments after chemoradiotherapy. Of them, 186 patients underwent radical surgery with lymph node dissection. MAIN OUTCOME MEASURES: The histopathological findings of resected tissues were compared with the preoperative endoscopic findings. Twelve patients refused radical surgery and chose watchful waiting; their outcomes were compared with the outcomes of patients who underwent radical surgery.
RESULTS: The endoscopic criteria correlated well with tumor regression grading. The sensitivity and specificity for a pathological complete response were 65.0% to 87.1% and 39.1% to 78.3%. However, endoscopic assessment could not fully discriminate pathological complete responses, and the outcomes of patients who underwent watchful waiting were considerably poorer than the patients who underwent radical surgery. Eventually, 41.7% of the patients who underwent watchful waiting experienced uncontrollable local failure, and many of these occurrences were observed more than 3 years after chemoradiotherapy. LIMITATIONS: The number of the patients treated with the watchful waiting strategy was limited, and the selection was not randomized.
CONCLUSIONS: Although endoscopic assessment after chemoradiotherapy correlated with pathological response, it is unsuitable for surveillance of patients treated via a nonoperative approach. Incorporation of a "watchful waiting" strategy without establishing proper surveillance protocols and salvage strategies might result in poor local control.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28267003     DOI: 10.1097/DCR.0000000000000742

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  9 in total

Review 1.  Rectal MRI radiomics inter- and intra-reader reliability: should we worry about that?

Authors:  Henry C Kwok; Charlotte Charbel; Jayasree Chakraborty; Natally Horvat; Sofia Danilova; Joao Miranda; Natalie Gangai; Iva Petkovska
Journal:  Abdom Radiol (NY)       Date:  2022-04-02

2.  Clinicopathologic determinants of pathologic treatment response in neoadjuvant treated rectal adenocarcinoma.

Authors:  Iván González; Philip S Bauer; William C Chapman; Zahra Alipour; Rehan Rais; Jingxia Liu; Deyali Chatterjee
Journal:  Ann Diagn Pathol       Date:  2019-12-14       Impact factor: 2.090

3.  Adoption of Organ Preservation and Surgeon Variability for Patients with Rectal Cancer Does Not Correlate with Worse Survival.

Authors:  Jin K Kim; Hannah Thompson; Rosa M Jimenez-Rodriguez; Fan Wu; Francisco Sanchez-Vega; Garrett M Nash; Jose G Guillem; Philip B Paty; Iris H Wei; Emmanouil P Pappou; Maria Widmar; Martin R Weiser; J Joshua Smith; Julio Garcia-Aguilar
Journal:  Ann Surg Oncol       Date:  2021-10-03       Impact factor: 5.344

4.  Multimodal CEA-targeted fluorescence and radioguided cytoreductive surgery for peritoneal metastases of colorectal origin.

Authors:  Jan Marie de Gooyer; Fortuné M K Elekonawo; Andreas J A Bremers; Otto C Boerman; Erik H J G Aarntzen; Philip R de Reuver; Iris D Nagtegaal; Mark Rijpkema; Johannes H W de Wilt
Journal:  Nat Commun       Date:  2022-05-12       Impact factor: 17.694

5.  Prognostic Significance of Tumor Regression in Locally Advanced Rectal Cancer after Preoperative Radiochemotherapy.

Authors:  Mirko Omejc; Maja Potisek
Journal:  Radiol Oncol       Date:  2017-12-07       Impact factor: 2.991

6.  Sensitivity of Various Evaluating Modalities for Predicting a Pathologic Complete Response After Preoperative Chemoradiation Therapy for Locally Advanced Rectal Cancer.

Authors:  Sungwoo Jung; Anuj Parajuli; Chang Sik Yu; Seong Ho Park; Jong Seok Lee; Ah Young Kim; Jong Lyul Lee; Chan Wook Kim; Yong Sik Yoon; In Ja Park; Seok-Byung Lim; Jin Cheon Kim
Journal:  Ann Coloproctol       Date:  2019-10-31

7.  Endoscopy and magnetic resonance imaging-based prediction of ypT stage in patients with rectal cancer who received chemoradiotherapy: Results from a prospective study of 110 patients.

Authors:  Min Soo Cho; HonSoul Kim; Yoon Dae Han; Hyuk Hur; Byung Soh Min; Seung Hyuk Baik; Jae Hee Cheon; Joon Seok Lim; Kang Young Lee; Nam Kyu Kim
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

8.  Analysis of long-term oncological results of clinical versus pathological responses after neoadjuvant treatment in locally advanced rectal cancer.

Authors:  Mariana F Coraglio; Martin A Eleta; Mirta R Kujaruk; Javier H Oviedo; Enrique L Roca; Guillermo A Masciangioli; Guillermo Mendez; Ilma S Iseas
Journal:  World J Surg Oncol       Date:  2020-11-30       Impact factor: 2.754

Review 9.  Watch and wait approach in rectal cancer: Current controversies and future directions.

Authors:  Fernando López-Campos; Margarita Martín-Martín; Roberto Fornell-Pérez; Juan Carlos García-Pérez; Javier Die-Trill; Raquel Fuentes-Mateos; Sergio López-Durán; José Domínguez-Rullán; Reyes Ferreiro; Alejandro Riquelme-Oliveira; Asunción Hervás-Morón; Felipe Couñago
Journal:  World J Gastroenterol       Date:  2020-08-07       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.